{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["390(10106)"],"submitter":["Coleman RL"],"funding":["Stand Up To Cancer","Ergomed","Amgen","Cancer Research UK","University College London","US Department of Defense Ovarian Cancer Research Program","OncoMed","Ovarian Cancer Research Fund","Merck","Ajinomoto","Regeneron","Roche","Immunogen","Janssen","Clovis Oncology","Millennium","AstraZeneca","Experimental Cancer Medicine Centres at Glasgow","V Foundation Translational Award","EMD Serono","AbbVie","VentiRx","Ovarian Cancer Research Fund Alliance","Stand Up to Cancer is a programme of the Entertainment Industry Foundation","Genentech","Medical Research Council","National Ovarian Cancer Coalition Dream Team Translational Research Grant","NCI NIH HHS","Memorial Sloan Kettering Cancer Center","Array Biopharma","GamaMabs and Merus","American Association for Cancer Research","Esperance"],"journal":["Lancet (London, England)"],"pagination":["1949-1961"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5901715"],"repository":["biostudies-literature"],"pubmed_title":["Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial."],"pmcid":["PMC5901715"],"funding_grant_id":["P30 CA016058","P30 CA016672","OC120506","G0501974","P30 CA008748","SU2C-AACR-DT16–15","1515685","15973","G0601891"],"pubmed_authors":["Slomovitz BM","Shapira-Frommer R","Holloway RW","Aghajanian C","Kovel S","Zamagni C","Chen LM","Giordano H","Goh JC","Harding TC","Garcia-Donas J","Ledermann JA","Scambia G","Polcher M","Isaacson J","Gladieff L","Goble S","Sun J","Medioni J","Tamberi S","Pignata S","Banerjee SN","Neunhoffer T","Lorusso D","Safra T","Tredan O","Palacio I","Welch S","Leary A","Sabbatini RF","Harnett P","Provencher D","Gabra HG","Konecny GE","Buck M","ARIEL3 investigators","El-Balat A","Birrer MJ","Vanderkwaak T","Colombo N","Elit L","Buss MK","Floquet A","Dirix L","Amit A","Ma L","Weberpals JI","Lin KK","Krabisch P","Coleman RL","Maloney L","Friedlander ML","Herraez AC","Lortholary A","Joly F","Lotz J","Ghatage P","Grace C","Oaknin A","O'Malley DM","Jackson D","Chambers SK","Hanle C","Gancedo MA","Morgan MA","Vulfovich M","Kichenadasse G","Powell M","Armstrong DK","Romero I","Swisher EM","Oza AM","Scott CL","Leviov M","Drew Y","Denys H","Parkinson C","Dean A","Fong PC","Vergote I","Clamp A","Guerra EM","Plante M","Sanchez A","O'Donnell A","Morris RT","McNeish IA","Wimberger P","Cameron T","Stemmer S","Mutch DG","You B","Bologna A","Raponi M"],"additional_accession":[]},"is_claimable":false,"name":"Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.","description":null,"dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Oct","modification":"2026-04-30T19:16:57.585Z","creation":"2025-04-06T08:27:21.095Z"},"accession":"S-EPMC5901715","cross_references":{"pubmed":["28916367"],"doi":["10.1016/S0140-6736(17)32440-6","10.1016/s0140-6736(17)32440-6"]}}